Skip to content

FA Clinical Research

Active Private limited companyfounded 2017active for 9 yearsKlein Holland 61, 1840 LonderzeelKBO/BCE: BE 0679.774.515

Board

1 director, no change since August 2017
Director (not named in the articles)
appointed by deed of 16-08-2017 term without a fixed end
listed in the 2025 annual accounts, filed on 15-06-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“De vennootschap is verbonden door de handelingen van het bestuursorgaan…”
deed of 12-02-2024

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today

Manager (not named in the articles)
Board
Mandates as a list
    • Manager (not named in the articles), from 11-08-2017 to date

Control

Founder
This company
FA Clinical Research
Equity €247,120
Loss €37,753 in 2025

Capital

Contribution
€18,600
Shares
100
Contribution per share
€186
Equity per share
€2,471 in 2025
Source
2025 annual accounts

Articles of association

deed of 12-02-2024 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
Op naam, effectenregister van effecten op naam met WVV-vermeldingen
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
Helft overdrager en helft kopers naar evenredigheid aantal bij meer kopers, nietigheid
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Monday of May at 15:00

Shareholders

At incorporation deed of 16-08-2017 ↗
  • 100 shares (100%) · €18,600 in cash

Capital transactions

Capital over time
  1. 12-02-2024 Converted to unavailable equity
  2. 16-08-2017 Incorporation · €18,600 · 100 shares

Next steps